<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04480203</url>
  </required_header>
  <id_info>
    <org_study_id>CABC - Kreftfor project - SEB</org_study_id>
    <nct_id>NCT04480203</nct_id>
  </id_info>
  <brief_title>Coping After Breast Cancer</brief_title>
  <acronym>CABC</acronym>
  <official_title>Coping After Breast Cancer - CABC - Stressmestring Etter Brystkreft - SEB</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cancer Registry of Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cancer Registry of Norway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Determine the level of common HRQoL issues among breast cancer patients just after
           diagnosis and later compared with age-matched controls without breast cancer.

        2. Modify digital interventions for cancer stress management, CBSM and MBI, based on
           existing interventions and expertise in clinical medicine as well as information
           technology expertise.

        3. Determine the acceptability and feasibility of two (CBSM and MBI) digital intervention
           programs for patients with breast cancer.

        4. Determine whether digital CBSM or MBI can effectively improve HRQoL (or avoid onset of
           HRQoL problems) for patients with breast cancer, compared to a control group, in a
           randomized clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After completing the baseline HRQoL assessment, eligible breast cancer patients will be
      invited to participate in a clinical trial.

      This protocol focuses on the clinical trial.

      Those who are willing will be randomly allocated to one of the following arms: a) Digital
      cognitive based stress management, b) Digital mindfulness based intervention or c) Control
      group.

      The intervention is based on a revised version of the Stressproffen app, which was developed
      by the Oslo University Hospital (Lise Solberg Nes, Elin Børøsund and others).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2035</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Initially a descriptive study of all breast cancer patients and non-cancer controls. Then an intervention study of breast cancer patients with two digital intervention arms and one control group.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>Yr 1</time_frame>
    <description>EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>Yr 2</time_frame>
    <description>EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>change baseline to Yr 1</time_frame>
    <description>EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>change baseline to Yr 2</time_frame>
    <description>EORTC health related quality of life (HRQoL) general questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-B23</measure>
    <time_frame>Yr 1</time_frame>
    <description>EORTC health related quality of life (HRQoL) breast cancer questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-B23</measure>
    <time_frame>Yr 2</time_frame>
    <description>EORTC health related quality of life (HRQoL) breast cancer questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-B23</measure>
    <time_frame>change baseline to Yr 1</time_frame>
    <description>EORTC health related quality of life (HRQoL) breast cancer questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EORTC QLQ-B23</measure>
    <time_frame>change baseline to Yr 2</time_frame>
    <description>EORTC health related quality of life (HRQoL) breast cancer questionnaire. Unit is summary score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuropathy (FACT GOG-NTX and -ES)</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>neuropathy questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatigue</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>Chalders' fatigue questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>PHQ-4 questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mindfulness</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>Baer 2006 mindfulness questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stress</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>Cohens perceived stress scale. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coping</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>TOMCATS questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>selected questions fro SUSSH questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>subjective health</measure>
    <time_frame>change from baseline to Yr 1</time_frame>
    <description>SF-36 questionnaire. Unit is summary score.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">834</enrollment>
  <condition>Breast Cancer Patients</condition>
  <condition>Health, Subjective</condition>
  <arm_group>
    <arm_group_label>Cognitive based stress management (CBSM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cognitive based digital intervention (Stressproffen cognitive arm, Stressproffen 2A)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness based intervention (MBI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mindfulness based digital intervention (Stressproffen mindfulness arm, Stressproffen 2B)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stressproffen cognitive based stress management</intervention_name>
    <description>The participants will download an app (Stressproffen 2A) with cognitive based stress management.</description>
    <arm_group_label>Cognitive based stress management (CBSM)</arm_group_label>
    <other_name>CBSM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stressproffen mindfulness based intervention</intervention_name>
    <description>The participants will download an app (Stressproffen 2B) with mindfulness based intervention</description>
    <arm_group_label>Mindfulness based intervention (MBI)</arm_group_label>
    <other_name>MBI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>The participants will receive no app. (They will be able to download it after the end of the 3 year study).</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first occurrence breast cancer diagnosed from Jan 1, 2020

          -  non-metastatic cancer stage 0-III

          -  HER2+ or triple negative

          -  (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female breast cancer patients</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giske Ursin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cancer Registry of Norway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giske Ursin, MD, PhD</last_name>
    <phone>+4722451300</phone>
    <email>giske.ursin@kreftregisteret.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ine M Larsson</last_name>
    <phone>+4722928985</phone>
    <email>ine.marie.larsson@kreftregisteret.no</email>
  </overall_contact_backup>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 9, 2020</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Health Related Quality of Life</keyword>
  <keyword>Stress management intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 23, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT04480203/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

